Evaluation of a multiplexed, multispecies nuclear receptor assay for chemical hazard assessment.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 19 06 2020
revised: 21 09 2020
accepted: 05 10 2020
pubmed: 14 10 2020
medline: 17 7 2022
entrez: 13 10 2020
Statut: ppublish

Résumé

Sensitivity to potential endocrine disrupting chemicals in the environment varies across species and is influenced by sequence conservation of their nuclear receptor targets. Here, we evaluated a multiplexed, in vitro assay testing receptors relevant to endocrine and metabolic disruption from five species. The TRANS-FACTORIAL™ system of human nuclear receptors was modified to include additional species: mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). Receptors regulating endocrine function and xenobiotic recognition were included, specifically: ERα, ERβ, AR, TRα, TRβ, PPARγ and PXR. The assay, ECOTOX-FACTORIAL™, was evaluated with 191 chemicals enriched with known receptor ligands. Hierarchical clustering of potency values demonstrated strong coherence of receptor families. Interspecies comparisons of responses within a receptor family showed moderate to high concordance for potencies under 50 μM. PPARγ showed high concordance between mammalian species, 89%, but only 63% between mammalian and zebrafish. For chemicals with potencies below 1 μM, concordances were 89-100% for all receptors except PXR. Concordance showed a strong positive relationship to ligand-binding domain sequence similarity and critical amino acid residues obtained by the Sequence Alignment to Predict Across Species Susceptibility (SeqAPASS) tool. In combination with SeqAPASS, ECOTOX-FACTORIAL may provide efficient screening of important receptors to identify species of high priority for effects monitoring.

Identifiants

pubmed: 33049310
pii: S0887-2333(20)30566-X
doi: 10.1016/j.tiv.2020.105016
pii:
doi:

Substances chimiques

Hazardous Substances 0
Receptors, Cytoplasmic and Nuclear 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105016

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Auteurs

Keith A Houck (KA)

Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: houck.keith@epa.gov.

Anita Simha (A)

ORAU, Contractor to U.S. Environmental Protection Agency through the National Student Services Contract, United States.

Audrey Bone (A)

Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.

Jon A Doering (JA)

National Research Council, 6201 Congdon Blvd., Duluth, MN 55804, USA.

Sara M F Vliet (SMF)

Office of Research and Development, Center for Computational Toxicology and Ecology, Great Lakes Toxicology and Ecology Division, Oak Ridge Institute for Science and Education, U.S. Environmental Protection Agency, Duluth, MN 55804, USA.

Carlie LaLone (C)

Great Lakes Toxicology and Ecology Division, Office of Research and Development, U.S. Environmental Protection Agency, Duluth, MN, United States of America.

Alex Medvedev (A)

Attagene, Inc., 7030 Kit Creek Rd, Morrisville, NC 27560, United States of America.

Sergei Makarov (S)

Attagene, Inc., 7030 Kit Creek Rd, Morrisville, NC 27560, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH